US approves new oral weight-loss pill developed by Eli Lilly

Called Foundayo, the tablet becomes the second one to receive FDA’s green light after Novo Nordisk’s Wegovy

The Guardian
Mounjaro maker wants NHS drug price rises in return for more investment in UK

US firm Eli Lilly, which is also pushing for end to rebate scheme, optimistic about talks with ministers

The Guardian
As patents on weight-loss drugs expire, doctors and patients hotly anticipate cheaper generics
Now that patents have expired, generic versions of Novo Nordisk's blockbuster weight-loss drugs could arrive in Canada within months, according to experts. Doctors say these cheaper versions will improve access and could also change societal perceptions around weight loss and reduce the cost and burden on the health-ca...
https://www.cbc.ca/news/health/generic-ozempic-canada-waiting-9.7142339?cmp=rss
As patents on weight-loss drugs expire, doctors and patients hotly anticipate cheaper generics
Now that patents have expired, generic versions of Novo Nordisk's blockbuster weight-loss drugs could arrive in Canada within months, according to experts. Doctors say these cheaper versions will improve access and could also change societal perceptions around weight loss and reduce the cost and burden on the health-ca...
https://www.cbc.ca/news/health/generic-ozempic-canada-waiting-9.7142339?cmp=rss
As patents on weight-loss drugs expire, doctors and patients hotly anticipate cheaper generics
Now that patents have expired, generic versions of Novo Nordisk's blockbuster weight-loss drugs could arrive in Canada within months, according to experts. Doctors say these cheaper versions will improve access and could also change societal perceptions around weight loss and reduce the cost and burden on the health-ca...
https://www.cbc.ca/news/health/generic-ozempic-canada-waiting-9.7142339?cmp=rss
Molecule in python blood could pave way for new obesity drugs, scientists say

Researchers find snake metabolite that suppresses appetite of obese mice ‘without some of side-effects’ of GLP-1 drugs

The Guardian
Illicit weight loss drug markets aren't just criminal activity—they're market validation signaling extraordinary demand. Our analysis examines the systemic risks and opportunities for $LLY in this paradoxical landscape. https://post.kapualabs.com/c9zbm4th #Pharmaceuticals #SupplyChain #MarketDynamics #WeightLossDrugs
GLP-1 diabetes drugs could stop anxiety and depression worsening, study finds

Drugs such as semaglutide may be useful for mental health conditions associated with diabetes, authors say

The Guardian
What’s behind the injectable peptide craze? – podcast

Madeleine Finlay hears from journalist Adrienne Matei and from Dr Anna Barnard, an associate professor at Imperial College London who researches peptides

The Guardian